B Swearingen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B Swearingen

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

The Journal of Clinical Endocrinology and Metabolism|May 20, 1998

Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomasL Katznelson, J S Bogan, J R Trob, et al.

Molecular and Cellular Biochemistry|March 28, 2001

Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicityA Castilleja, N E Ward, C A O'Brian, et al.

The Journal of Clinical Endocrinology and Metabolism|April 17, 2008

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

The Journal of Clinical Endocrinology and Metabolism|May 20, 1998

Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomasL Katznelson, J S Bogan, J R Trob, et al.

Molecular and Cellular Biochemistry|March 28, 2001

Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicityA Castilleja, N E Ward, C A O'Brian, et al.

The Journal of Clinical Endocrinology and Metabolism|April 17, 2008

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.

Pageof 4